Social Support Build Resilience in Multidrug-Resistant Tuberculosis Patients: A Cross-Sectional Study in MDR-TB Patient Support Group

Putri Wulan Akbar, Lailia Nur Rachma, Zainabur Rahmah, Muhammad Iqbal Firdaus, Bryka Vian Nanggali

Abstract


Background: Multidrug-resistant tuberculosis (MDR-TB) patient faces multi-dimensional challenges due to the physical factor, long-term treatment, negative stigma, and psychosocial challenge. Addressing these issues patient requires a resilience. The formation of resilience is influenced by both internal and external factors, including social support. This study purposed to assess the social support impact on resilience in MDR-TB patients. Methods: This study was an observational analytic study with cross sectional design. A total of 33 respondents with MDR-TB confirmed, a member of MDR-TB support group, and under treatment were involved. The social support level was measured using the ISEL-12 (Interpersonal Support Evaluation List) questionnaire, while the level of resilience was assessed using the CD-RISC-25 (Connor-Davidson Resilience Scale). Spearman correlation test in SPSS Ver 24.0 was used to examine the relationship between social support and resilience among patients with MDR-TB. Results: Majority of respondents (17 respondents, 51.6%) have good social support and 23 respondents (69.7%) exhibited a good level of resilience. The Spearman correlation test revealed a significant positive correlation between social support and resilience, with a p-value of 0.030 and a moderate strength correlation coefficient (r) of 0.378. Conclusion: This finding showed that good social support toward MDR-TB patients gives positive impact to patients’ resilience. Thus strengthens the system of social support in support group is important to decrease the psychosocial challenges and help to succeed the treatment.


Keywords


Keywords: Social support, resilience, psychosocial aspect, MDR-TB

References


World Health Organization. Global Tuberculosis Report. Global tuberculosis report 2024. Geneva: World Health Organization; 2024. Licence: CC BY-NC-SA 3.0 IGO. Cataloguing-in-Publication (CIP) data. CIP data are available at https://iris.who.int/. Sales. 2024. 1–98 p.

Xi Y, Zhang W, Qiao RJ, Tang J. Risk factors for multidrug-resistant tuberculosis: A worldwide systematic review and meta-analysis. PLoS One [Internet]. 2022;17(6 June):1–15. Available from: http://dx.doi.org/10.1371/journal.pone.0270003

Setyawan MF, Mertaniasih NM, Soedarsono. The Profile of Multidrug Tuberculosis Regimen and Treatment Outcomes in Pulmonary MDR-TB Patients at the Tertiary Referral Hospital Dr. Soetomo, East Java, Indonesia: A Seven-Year Retrospective Study on Bedaquiline. Acta Med Indones. 2023;55(4):430–9.

Sharma S, N SK, Kokane A, Pakhare AP, Nawaz MM, Joshi A. Quality of Life Amongst Multidrug-Resistant TB Patients: An Exploratory Study About Distributive Dimensions and Interactions. Cureus. 2022;14(9).

Atif M, Ahmed W, Nouman Iqbal M, Ahmad N, Ahmad W, Malik I, et al. Frequency and Factors Associated With Adverse Events Among Multi-Drug Resistant Tuberculosis Patients in Pakistan: A Retrospective Study. Front Med. 2022;8(March):1–11.

Chen X, Wu R, Xu J, Wang J, Gao M, Chen Y, et al. Prevalence and associated factors of psychological distress in tuberculosis patients in Northeast China: a cross-sectional study. BMC Infect Dis. 2021;21(1):1–12.

Pang Y, Liu R, Song Y, Lv Z, Gao M, Nie L, et al. High Incidence of Psychiatric Disorders Associated with Cycloserine Treatment of Multidrug-Resistant Tuberculosis Patients: A Cohort Study in Beijing, China. Infect Drug Resist. 2022;15:3725–32.

Caminero JA, Cayla JA, García-García JM, García-Pérez FJ, Palacios JJ, Ruiz-Manzano J. Diagnosis and Treatment of Drug-Resistant Tuberculosis. Arch Bronconeumol. 2017;53(9):501–9.

Wen S, Yin J, Sun Q. Impacts of social support on the treatment outcomes of drug-resistant tuberculosis: A systematic review and meta-analysis. BMJ Open. 2020;10(10):1–11.

Pop TB Indonesia. Profil Lembaga Perhimpunan Organisasi Pasien (POP) TB Indonesia. 2020; Available from: https://poptbindonesia.org/wp-content/uploads/2020/10/Profil-POP-TB-Indonesia-1.pdf

Daftary A, Mondal S, Zelnick J, Friedland G, Seepamore B, Boodhram R, et al. Dynamic needs and challenges of people with drug-resistant tuberculosis and HIV in South Africa: a qualitative study. Lancet Glob Heal. 2021;9(4):e479–88.

Nagarajan K, Kumarswamy K, Begum R, Panibatla V, Singarajipura A, Adepu R, et al. Self-driven solutions and resilience adapted by people with drug-resistant tuberculosis and their caregivers in Bengaluru and Hyderabad, India: a qualitative study. Lancet Reg Heal - Southeast Asia [Internet]. 2024;22:100372. Available from: https://doi.org/10.1016/j.lansea.2024.100372

Guariglia P, Palmiero M, Giannini AM, Piccardi L. The Key Role of Empathy in the Relationship between Age and Social Support. Healthc. 2023;11(17):1–11.

Hyun Kim D, Lee HK, Won Kim J, Lee K. Reliability and Validity of the Korean Version of Interpersonal Support Evaluation List-12 (ISEL-12). J Korean Neuropsychiatr Assoc [Internet]. 2012;51:416–21. Available from: www.knpa.or.kr

Wang Y, Xu J, Yang S, Jiang J, Gao J. Exploratory graph analysis on the Connor–Davidson Resilience Scale (CD-RISC) among older adults in China. Sci Rep. 2023;13(1):1–12.

Wojujutari AK, Idemudia ES, Ugwu LE. Evaluation of reliability generalization of Conner-Davison Resilience Scale (CD-RISC-10 and CD-RISC-25): A Meta-analysis. PLoS One [Internet]. 2024;19(11 November):1–18. Available from: http://dx.doi.org/10.1371/journal.pone.0297913

Khan MA, Bilal W, Asim H, Rahmat ZS, Essar MY, Ahmad S. MDR-TB in Pakistan: Challenges, efforts, and recommendations. Ann Med Surg [Internet]. 2022;79(June):104009. Available from: https://doi.org/10.1016/j.amsu.2022.104009

Rashmi Sharma, Harsh Bakshi, Shailesh Prajapati, Gneyaa S. Bhatt, Rajesh Mehta, Kiran C. Rami, Prakash Mehta, Tejas Shah, Roshni Dave AP. Prevalence and Determinants of Depression among Multi Drug Resistant (MDR) TB cases registered under National Tuberculosis Elimination Program in Ahmedabad City. Indian J Community Med. 2022;47(1):45–9.

Riepenhausen A, Wackerhagen C, Reppmann ZC, Deter HC, Kalisch R, Veer IM, et al. Positive Cognitive Reappraisal in Stress Resilience, Mental Health, and Well-Being: A Comprehensive Systematic Review. Emot Rev. 2022;14(4):310–31.

Sahasrabudhe T, K MN. Quantitative Study of Physical , Social , Psychological , and Environmental Challenges Faced by Patients With Drug-Resistant Tuberculosis. 2024;16(9):1–12.

Dilas D, Flores R, Morales-García WC, Calizaya-Milla YE, Morales-García M, Sairitupa-Sanchez L, et al. Social Support, Quality of Care, and Patient Adherence to Tuberculosis Treatment in Peru: The Mediating Role of Nurse Health Education. Patient Prefer Adherence. 2023;17(December 2022):175–86.

Adejumo OA, Daniel OJ, Jinabhai C, Haffejee F. Treatment Adherence among People with Drug ‑ resistant Tuberculosis in Lagos Nigeria : The Effects of Stigma , Resilience , Social Support , and Temporal Discounting. 2025;36–42.

Ye ZJ, Qiu HZ, Li PF, Liang MZ, Zhu YF, Zeng Z, et al. Predicting changes in quality of life and emotional distress in Chinese patients with lung, gastric, and colon-rectal cancer diagnoses: the role of psychological resilience. Psychooncology. 2017;26(6):829–35.

Kim GM, Lim JY, Kim EJ, Park SM. Resilience of patients with chronic diseases: A systematic review. Heal Soc Care Community. 2019;27(4):797–807.

Cremers AL, Gerrets R, Colvin CJ, Maqogi M, Grobusch MP. Tuberculosis patients and resilience: A visual ethnographic health study in Khayelitsha, Cape Town. Soc Sci Med. 2018;209(May):145–51.

Li X, Wang B, Tan D, Li M, Zhang D, Tang C, et al. Effectiveness of comprehensive social support interventions among elderly patients with tuberculosis in communities in China: A community-based trial. J Epidemiol Community Health. 2018;72(5):369–75.




DOI: https://doi.org/10.15408/avicenna.v5i2.42615

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

View My Stats